Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
Thirty-five out of every 100 job applicants in the pharmaceutical or clinical trial space in India “are lying about their credentials”, says a report by Delhi-based employee screening firm AuthBridge.
According to a report in India’s Economic Times, AuthBridge sifted through three years of applicant data from over 500 companies and found that pharma/clinical trials is among the industries with the “highest employee discrepancies”.
The trend is said to be most common among the 30-49 age groups, when “the applicant doesn’t mind enriching his or her educational qualification,” says AuthBridge CEO, Ajay Trehan.
He goes on: “One candidate had furnished the educational qualifications of his ex-boss, another had used her deceased sister’s credentials while applying for a job.”
Pharma sector hiring grew by 24% last year compare with 2012, according to a report by headhunting firm Randstad. But most of the recent hires in senior positions are from outside the industry, noted a spokesperson for a large Indian pharma firm, because there is uncertainty about the quality of people available in the current market. In areas such as R&D, however, research and development, there are no options but to look for those within the industry. As a result, this particular executive’s firm has “tightened investigation of our potential employees.”
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.